Erratum to ``Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm¿¿ [Neurologia. 2020;35(6):357¿362] G. Valero-López; E. Carreón-Guarnizo; R. Hernández-Clares; F. Iniesta-Martínez; J. Jiménez-Veiga; A. Moreno-Docon; M.A. Iborra-Bendicho; E. Aznar-Robles; M.F. Hellín-Gil; A. Morales-Ortiz; J.E. Meca-Lallana;

SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis R. Piñar Morales; M.A. Ramírez Rivas; F.J. Barrero Hernández;

Early beginning of alemtuzumab: Changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study J.E. Meca-Lallana; J.C. Álvarez-Cermeño; B. Casanova Estruch; G. Izquierdo Ayuso; R. Ortiz Castillo; A. Rodríguez-Antigüedad; C. Calles Hernández;